February 2019 Briefing – Geriatrics

Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for February 2019. This roundup includes the latest research news from journal articles, as […]

Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Risk Factors ID’d for Site Infection After Orthopedic Surgery in Seniors

THURSDAY, Feb. 28, 2019 (HealthDay News) — Five risk factors are independently associated with surgical site infection among geriatric patients undergoing elective orthopedic surgery, according to a study published online Feb. 20 in the International Wound Journal.

Abstract/Full Text (subscription or payment may be required)

Lowering BP, Lipids in Healthy Elderly Has No Cognitive Effect

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — Candesartan plus hydrochlorothiazide, rosuvastatin, or their combination do not impact cognitive decline among older people, according to a study published online Feb. 27 in Neurology.

Abstract/Full Text (subscription or payment may be required)

Ultrasound of Calcaneus Efficient for Screening Bone Health

TUESDAY, Feb. 26, 2019 (HealthDay News) — Ultrasonography (US) of the calcaneus is efficient for screening bone health, according to a study published in the March issue of the Journal of the American Osteopathic Association.

Abstract/Full Text

Stereotactic Radiation Feasible for Oligometastatic Cancer

TUESDAY, Feb. 26, 2019 (HealthDay News) — Stereotactic ablative radiation therapy (SABR) for recurrent oligometastatic cancer is a feasible and tolerable treatment option, according to a phase 2 study published in the January issue of the International Journal of Radiation Oncology, Biology, Physics.

Abstract/Full Text

Prognostic Bleeding Risk Models Developed for Aspirin Use

MONDAY, Feb. 25, 2019 (HealthDay News) — Prognostic bleeding risk models that can estimate the absolute bleeding harms of aspirin have been developed for individuals in whom aspirin is being considered for primary prevention of cardiovascular disease (CVD), according to a study published online Feb. 26 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

2014 to 2017 Saw Improvement in Burnout for U.S. Physicians

MONDAY, Feb. 25, 2019 (HealthDay News) — From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.

Abstract/Full Text

Preoperative Phone Visits for Cataract Patients Safe, Efficient

MONDAY, Feb. 25, 2019 (HealthDay News) — Phone visits can safely substitute for a standard, in-person history and physical (H&P) in patients undergoing cataract surgery, according to a study published online Feb. 7 in the Journal of General Internal Medicine.

Abstract/Full Text (subscription or payment may be required)

National Health Spending Set to Increase 5.5 Percent Annually

1 | 2 | 3 | 4 | 5 | 6 | 7
Page 1 of 7
Next »